Low-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 30 Jul 2011 New trial record